You are here: Industry Insights > Amgen

News List

Amgen pays $50M for Molecular Partners’ preclinical bispecific fiercebiotech
December 25, 2018
Amgen is paying Molecular Partners $50 million (€44 million) upfront for global rights to preclinical anti-cancer immune cell activator MP0310.....
Amgen cuts US price of cholesterol drug by 60% pharmaphorum
December 20, 2018
Amgen is cutting the US price of its cholesterol drug Repatha by 60%, following a similar decision by rivals Sanofi and Regeneron earlier this year.
Amgen and Molecular Partners to develop immune-oncology product pharmaceutical-technology
December 20, 2018
Amgen has collaborated with Swiss biopharmaceutical company Molecular Partners to develop and commercialise a pre-clinical immune-oncology candidate, MP0310....
Amgen Golden Tickets provide startup companies with free lab space to further advance innovative science and technology worldpharmanews
December 19, 2018
Amgen and LabCentral today announced that Kernal Biologics and PanTher Therapeutics have each won the Amgen Golden Ticket at LabCentral.
Vect-Horus, Amgen, Bristol-Myers Squibb pharmaceutical-technology
December 17, 2018
Vect-Horus has signed a research agreement with Janssen Pharmaceuticals for the development of neurodegenerative disease treatments.....
Amgen, Direct Relief Partner to help cancer patients In 18 countries biospectrumasia
December 17, 2018
The first shipments of the nearly 110,000 units of donated medicines have already reached cancer clinics in destination countries and are available to patients
Amgen partners with Magellan on patient care for difficult-to-treat diseases pharmaceutical-technology
December 13, 2018
Amgen has entered a partnership with Magellan Rx Management to improve care for patients suffering with chronic, difficult-to-treat diseases......
Amgen donate $2m towards increasing diversity in clinical trials pharmafile
December 13, 2018
American multinational Amgen has teamed up with the Lazarex Cancer Foundation in support of an initiative aimed at increasing access to clinical trials for those of all backgrounds, in the United States.
Entera Bio, Amgen Announce Strategic Research Collaboration americanpharmaceuticalreview
December 12, 2018
Entera Bio has entered into a research collaboration and license agreement with Amgen in inflammatory disease and other serious illnesses.....
Amgen contributes $2 million to groundbreaking program providing cancer patients of all backgrounds access to U.S. clinical trials worldpharmanews
December 12, 2018
Amgen and the Lazarex Cancer Foundation have teamed up to support more equitable access to clinical trials for cancer patients in the U.S.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page